. . "DHPG SodiumSYDTPNSC0716361" . "Ganciclovir sodiumSYDTPNSC0716361" . "RS-21592 SodiumCNNCI" . "C0282399"^^ . "Ganciclovir_Sodium"^^ . "Nucleic Acid, Nucleoside, or Nucleotide"^^ . "GANCICLOVIR SODIUMPTFDA02L083W284" . "FDA"^^ . "DHPG sodiumSYNCI" . "9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, Monosodium SaltSNNCI" . . . "Ganciclovir SodiumPTNCI" . "GCV sodiumSYNCI" . . "CymeveneFBNCI" . "GCV SodiumSYDTPNSC0716361" . . "DenosineFBNCI" . "716361"^^ . "Pharmacologic Substance"^^ . "C9H12N5O4.Na"^^ . "C1588"^^ . "BW-759UCNNCI" . "CytoveneSYDTPNSC0716361" . "Ganciclovir Sodium"^^ . "Cytovene-IVBRNCI" . "02L083W284"^^ . . "The sodium salt form of ganciclovir, a synthetic, antiviral, purine nucleoside analog with antiviral activity, especially against cytomegalovirus (CMV). Ganciclovir sodium is a prodrug that is phosphorylated and subsequently converted into its triphosphate form, the active metabolite ganciclovir-5-triphosphate (ganciclovir-TP), in the infected cells by cellular kinases. Ganciclovir-TP competes as a substrate with nucleotide triphosphates for viral DNA polymerase. Once it gets incorporated into DNA strand, it prevents further polymerization of DNA, thereby interfering with viral DNA replication.NCI" . "Ganciclovir Sodium"^^ . "107910-75-8"^^ . . "BW-759CNNCI" . "BIOLF-62CNNCI" . .